Moderna Expands Vaccine Manufacturing Campus

Published 5-19-2021

Moderna is initiating a major expansion of the 300,000-sf Moderna Technology Center in Norwood, Mass. Providing additional production capacity for mRNA vaccines and therapeutics, the 350,000-sf project will include the acquisition of a 240,000-sf structure and the renovation of existing buildings. Enabling a 50 percent increase in the plant's commercial COVID-19 vaccine output by early 2022, the new facilities will also support the creation of thousands of preclinical research samples per month. Transforming the site from a production and lab environment into an industrial technology complex, the sustainably designed expansion will accelerate the development of new pharmaceutical preservation and delivery modalities such as prefilled syringes and lyophilization. 

The Moderna Technology Center opened in July of 2018. The International Society for Pharmaceutical Engineering recognized the project in 2019 with the Facility of the Future award.